Christopher Evans
Concepts (498)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucus | 16 | 2025 | 74 | 4.850 |
Why?
| | Mucins | 24 | 2025 | 75 | 4.510 |
Why?
| | Mucin-5B | 25 | 2026 | 234 | 2.690 |
Why?
| | Mucin 5AC | 20 | 2026 | 70 | 2.510 |
Why?
| | Lung | 41 | 2026 | 4084 | 2.500 |
Why?
| | Asthma | 11 | 2025 | 1770 | 1.870 |
Why?
| | Mucociliary Clearance | 7 | 2021 | 43 | 1.750 |
Why?
| | Bronchial Hyperreactivity | 6 | 2025 | 96 | 1.730 |
Why?
| | Respiratory Mucosa | 19 | 2025 | 321 | 1.700 |
Why?
| | Lung Diseases, Obstructive | 3 | 2023 | 43 | 1.530 |
Why?
| | Idiopathic Pulmonary Fibrosis | 13 | 2025 | 691 | 1.240 |
Why?
| | Expectorants | 4 | 2023 | 23 | 1.130 |
Why?
| | Animals | 71 | 2026 | 37800 | 0.880 |
Why?
| | Fucosyltransferases | 1 | 2025 | 33 | 0.870 |
Why?
| | Electric Conductivity | 1 | 2024 | 84 | 0.850 |
Why?
| | Vagus Nerve | 4 | 2023 | 90 | 0.840 |
Why?
| | Alveolar Epithelial Cells | 3 | 2024 | 120 | 0.840 |
Why?
| | Electrolytes | 1 | 2024 | 54 | 0.830 |
Why?
| | Mice | 50 | 2026 | 18218 | 0.810 |
Why?
| | Bronchioles | 4 | 2024 | 29 | 0.780 |
Why?
| | Quantum Dots | 3 | 2012 | 37 | 0.780 |
Why?
| | Reflex | 1 | 2023 | 69 | 0.750 |
Why?
| | Lung Injury | 3 | 2024 | 236 | 0.740 |
Why?
| | Respiratory System | 6 | 2020 | 149 | 0.740 |
Why?
| | Disulfides | 2 | 2022 | 94 | 0.690 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 10 | 2024 | 919 | 0.660 |
Why?
| | Disease Models, Animal | 20 | 2025 | 4525 | 0.660 |
Why?
| | Respiratory Hypersensitivity | 1 | 2021 | 65 | 0.650 |
Why?
| | Homeostasis | 6 | 2020 | 635 | 0.640 |
Why?
| | Epithelial Cells | 11 | 2026 | 1102 | 0.640 |
Why?
| | Mice, Inbred C57BL | 30 | 2026 | 5954 | 0.630 |
Why?
| | Mice, Transgenic | 15 | 2026 | 2177 | 0.570 |
Why?
| | Peptides | 1 | 2024 | 985 | 0.560 |
Why?
| | Pulmonary Alveoli | 5 | 2025 | 383 | 0.540 |
Why?
| | Hypersensitivity | 1 | 2021 | 251 | 0.530 |
Why?
| | Eosinophilia | 1 | 2020 | 222 | 0.520 |
Why?
| | Immunity, Innate | 6 | 2026 | 842 | 0.500 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 108 | 0.480 |
Why?
| | Receptors, Muscarinic | 4 | 2001 | 20 | 0.470 |
Why?
| | Selenium Compounds | 2 | 2012 | 18 | 0.470 |
Why?
| | Chalcogens | 2 | 2012 | 3 | 0.460 |
Why?
| | Cadmium Compounds | 2 | 2012 | 31 | 0.460 |
Why?
| | Macrophages | 4 | 2024 | 1496 | 0.420 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 523 | 0.420 |
Why?
| | Eosinophils | 5 | 2026 | 316 | 0.420 |
Why?
| | Golgi Apparatus | 2 | 2026 | 99 | 0.420 |
Why?
| | Uteroglobin | 6 | 2024 | 30 | 0.390 |
Why?
| | Lung Diseases | 2 | 2018 | 780 | 0.390 |
Why?
| | Inflammation | 11 | 2022 | 2862 | 0.370 |
Why?
| | Pulmonary Emphysema | 2 | 2026 | 275 | 0.370 |
Why?
| | Cadmium | 1 | 2012 | 68 | 0.370 |
Why?
| | Lung Neoplasms | 5 | 2018 | 2643 | 0.360 |
Why?
| | Mice, Inbred BALB C | 8 | 2021 | 1246 | 0.360 |
Why?
| | Surface-Active Agents | 1 | 2012 | 91 | 0.360 |
Why?
| | Intracellular Space | 1 | 2012 | 64 | 0.350 |
Why?
| | Allergens | 3 | 2026 | 386 | 0.340 |
Why?
| | Cystic Fibrosis | 7 | 2021 | 1161 | 0.340 |
Why?
| | Humans | 53 | 2026 | 144298 | 0.340 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1244 | 0.330 |
Why?
| | Glycosylation | 2 | 2025 | 160 | 0.330 |
Why?
| | Mice, Knockout | 13 | 2025 | 3106 | 0.330 |
Why?
| | Ribonucleases | 3 | 2000 | 49 | 0.330 |
Why?
| | Organoselenium Compounds | 1 | 2010 | 10 | 0.320 |
Why?
| | Transcription Factors | 1 | 2018 | 1726 | 0.310 |
Why?
| | Gene Expression Regulation | 6 | 2025 | 2589 | 0.310 |
Why?
| | Exocytosis | 3 | 2019 | 85 | 0.310 |
Why?
| | Bronchi | 3 | 2016 | 262 | 0.300 |
Why?
| | Cilia | 4 | 2022 | 171 | 0.300 |
Why?
| | Polymers | 2 | 2024 | 484 | 0.300 |
Why?
| | Ovalbumin | 8 | 2026 | 190 | 0.300 |
Why?
| | Mucous Membrane | 4 | 2021 | 128 | 0.280 |
Why?
| | Airway Obstruction | 2 | 2016 | 153 | 0.280 |
Why?
| | Intestinal Mucosa | 3 | 2022 | 675 | 0.250 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2011 | 905 | 0.250 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2022 | 93 | 0.240 |
Why?
| | Munc18 Proteins | 2 | 2019 | 24 | 0.240 |
Why?
| | Gene Expression | 4 | 2018 | 1474 | 0.230 |
Why?
| | Bordetella bronchiseptica | 1 | 2025 | 2 | 0.230 |
Why?
| | Bordetella Infections | 1 | 2025 | 4 | 0.230 |
Why?
| | Duodenum | 1 | 2026 | 77 | 0.230 |
Why?
| | MicroRNAs | 4 | 2026 | 689 | 0.230 |
Why?
| | Oligosaccharides | 1 | 2025 | 60 | 0.220 |
Why?
| | Colloids | 3 | 2019 | 60 | 0.220 |
Why?
| | Phagocytosis | 3 | 2016 | 294 | 0.220 |
Why?
| | Anti-Inflammatory Agents | 2 | 2015 | 475 | 0.220 |
Why?
| | Lymphocytes | 1 | 2026 | 379 | 0.210 |
Why?
| | Hydrogen Bonding | 1 | 2024 | 168 | 0.210 |
Why?
| | Th2 Cells | 4 | 2017 | 171 | 0.200 |
Why?
| | Pneumonia | 4 | 2026 | 627 | 0.200 |
Why?
| | Food Hypersensitivity | 1 | 2026 | 163 | 0.200 |
Why?
| | Interleukin-13 | 4 | 2026 | 144 | 0.200 |
Why?
| | Bronchoalveolar Lavage Fluid | 6 | 2022 | 628 | 0.200 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 3 | 2024 | 45 | 0.200 |
Why?
| | Female | 33 | 2026 | 78137 | 0.190 |
Why?
| | Salts | 1 | 2023 | 37 | 0.190 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2022 | 10 | 0.190 |
Why?
| | Glycosyltransferases | 1 | 2022 | 16 | 0.190 |
Why?
| | Regeneration | 1 | 2024 | 194 | 0.190 |
Why?
| | Bleomycin | 5 | 2024 | 252 | 0.190 |
Why?
| | Energy Metabolism | 2 | 2024 | 925 | 0.190 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.190 |
Why?
| | Receptor, Muscarinic M2 | 5 | 2005 | 10 | 0.190 |
Why?
| | Bronchiectasis | 1 | 2024 | 112 | 0.190 |
Why?
| | Genetic Predisposition to Disease | 5 | 2018 | 2348 | 0.180 |
Why?
| | Glycoproteins | 2 | 2022 | 353 | 0.180 |
Why?
| | Glycolysis | 1 | 2024 | 340 | 0.180 |
Why?
| | Immunohistochemistry | 4 | 2015 | 1699 | 0.180 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 495 | 0.180 |
Why?
| | Fibroblasts | 2 | 2025 | 1017 | 0.180 |
Why?
| | Haemophilus influenzae | 4 | 2010 | 67 | 0.180 |
Why?
| | Colon | 2 | 2022 | 307 | 0.170 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 187 | 0.170 |
Why?
| | Pulmonary Eosinophilia | 1 | 2001 | 26 | 0.170 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 434 | 0.170 |
Why?
| | Metaplasia | 5 | 2008 | 57 | 0.170 |
Why?
| | Pulmonary Fibrosis | 1 | 2024 | 392 | 0.160 |
Why?
| | Mustard Gas | 1 | 2021 | 77 | 0.160 |
Why?
| | Macrophages, Alveolar | 2 | 2024 | 368 | 0.160 |
Why?
| | Pseudomonas Infections | 2 | 2020 | 220 | 0.160 |
Why?
| | Leukocyte Count | 1 | 2021 | 315 | 0.160 |
Why?
| | Substance P | 1 | 2000 | 38 | 0.160 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 89 | 0.160 |
Why?
| | Male | 25 | 2026 | 72263 | 0.160 |
Why?
| | Blood Proteins | 3 | 2000 | 233 | 0.160 |
Why?
| | Antigens | 4 | 2007 | 346 | 0.150 |
Why?
| | Gene Targeting | 2 | 2018 | 80 | 0.150 |
Why?
| | Syndecan-1 | 1 | 2019 | 43 | 0.150 |
Why?
| | Lymphocyte Subsets | 1 | 2019 | 79 | 0.150 |
Why?
| | Butadienes | 2 | 2009 | 36 | 0.150 |
Why?
| | Polystyrenes | 2 | 2009 | 36 | 0.150 |
Why?
| | Receptors, Interleukin-1 | 1 | 2020 | 211 | 0.150 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 72 | 0.140 |
Why?
| | Dexamethasone | 1 | 2001 | 366 | 0.140 |
Why?
| | Colitis, Ulcerative | 1 | 2020 | 148 | 0.140 |
Why?
| | Cysts | 1 | 2019 | 111 | 0.140 |
Why?
| | Hypoxia | 2 | 2017 | 1193 | 0.140 |
Why?
| | Bone Marrow Cells | 2 | 2017 | 320 | 0.140 |
Why?
| | Guinea Pigs | 5 | 2005 | 159 | 0.140 |
Why?
| | Paraquat | 1 | 2018 | 13 | 0.140 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 475 | 0.140 |
Why?
| | Herbicides | 1 | 2018 | 27 | 0.130 |
Why?
| | Macrophage Activation | 1 | 2019 | 186 | 0.130 |
Why?
| | Methacholine Chloride | 2 | 2015 | 50 | 0.130 |
Why?
| | Signal Transduction | 8 | 2022 | 5182 | 0.130 |
Why?
| | Thrombospondin 1 | 1 | 2017 | 28 | 0.130 |
Why?
| | Colitis | 1 | 2020 | 280 | 0.130 |
Why?
| | Schistosoma | 1 | 2017 | 28 | 0.130 |
Why?
| | Transgenes | 1 | 2018 | 190 | 0.130 |
Why?
| | Mucin-2 | 1 | 2016 | 2 | 0.130 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 132 | 0.130 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1762 | 0.120 |
Why?
| | Glucocorticoids | 1 | 2001 | 528 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 170 | 0.120 |
Why?
| | Leukocytes | 2 | 2016 | 291 | 0.120 |
Why?
| | Cytokines | 6 | 2021 | 2043 | 0.120 |
Why?
| | Bronchitis, Chronic | 1 | 2016 | 16 | 0.120 |
Why?
| | Mast Cells | 2 | 2021 | 146 | 0.120 |
Why?
| | Bacteria | 3 | 2020 | 888 | 0.120 |
Why?
| | Carcinogenesis | 1 | 2018 | 227 | 0.120 |
Why?
| | Kartagener Syndrome | 1 | 2016 | 31 | 0.120 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 116 | 0.120 |
Why?
| | Bronchoconstriction | 2 | 2011 | 29 | 0.120 |
Why?
| | Survival Analysis | 3 | 2018 | 1368 | 0.120 |
Why?
| | Neutrophils | 3 | 2017 | 1115 | 0.120 |
Why?
| | Neurons | 2 | 2005 | 1637 | 0.110 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 44 | 0.110 |
Why?
| | Thiocyanates | 1 | 2015 | 27 | 0.110 |
Why?
| | Qc-SNARE Proteins | 1 | 2015 | 8 | 0.110 |
Why?
| | Qb-SNARE Proteins | 1 | 2015 | 7 | 0.110 |
Why?
| | Aspergillus oryzae | 1 | 2015 | 4 | 0.110 |
Why?
| | Deoxycytidine Kinase | 1 | 2014 | 3 | 0.110 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 9 | 0.110 |
Why?
| | Models, Biological | 2 | 2013 | 1807 | 0.110 |
Why?
| | Mutation | 5 | 2018 | 4068 | 0.110 |
Why?
| | Cell Line | 4 | 2019 | 2821 | 0.110 |
Why?
| | Polysaccharides | 1 | 2014 | 86 | 0.100 |
Why?
| | Acute Lung Injury | 1 | 2017 | 300 | 0.100 |
Why?
| | Transcription, Genetic | 2 | 2018 | 1465 | 0.100 |
Why?
| | Smoking | 2 | 2018 | 1466 | 0.100 |
Why?
| | Species Specificity | 1 | 2015 | 572 | 0.100 |
Why?
| | Ear, Middle | 1 | 2013 | 84 | 0.100 |
Why?
| | Microbiota | 1 | 2021 | 781 | 0.100 |
Why?
| | Valerates | 1 | 2013 | 3 | 0.100 |
Why?
| | Bed Rest | 1 | 2013 | 14 | 0.100 |
Why?
| | Adenosine Triphosphate | 3 | 2022 | 500 | 0.090 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 26 | 0.090 |
Why?
| | Semiconductors | 1 | 2012 | 32 | 0.090 |
Why?
| | Genes, Essential | 1 | 2012 | 21 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2015 | 454 | 0.090 |
Why?
| | Muscle Development | 1 | 2013 | 113 | 0.090 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3520 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 971 | 0.090 |
Why?
| | Crystallization | 1 | 2012 | 140 | 0.090 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 61 | 0.090 |
Why?
| | Base Sequence | 3 | 2017 | 2171 | 0.090 |
Why?
| | Polymerization | 1 | 2012 | 130 | 0.090 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 206 | 0.090 |
Why?
| | Fibrosis | 2 | 2024 | 547 | 0.090 |
Why?
| | Bacterial Infections | 1 | 2013 | 246 | 0.090 |
Why?
| | Sarcopenia | 1 | 2013 | 91 | 0.090 |
Why?
| | Trichuris | 1 | 2011 | 3 | 0.090 |
Why?
| | Genes, ras | 2 | 2009 | 96 | 0.090 |
Why?
| | Trichuriasis | 1 | 2011 | 4 | 0.090 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2011 | 12 | 0.090 |
Why?
| | Antigens, Dermatophagoides | 1 | 2011 | 10 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2018 | 919 | 0.080 |
Why?
| | Integrases | 2 | 2010 | 122 | 0.080 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 59 | 0.080 |
Why?
| | Eosinophil Granule Proteins | 3 | 2000 | 15 | 0.080 |
Why?
| | Sepsis | 1 | 2017 | 642 | 0.080 |
Why?
| | Immune Tolerance | 1 | 2013 | 378 | 0.080 |
Why?
| | Bronchial Provocation Tests | 2 | 2011 | 47 | 0.080 |
Why?
| | Phosphines | 1 | 2010 | 18 | 0.080 |
Why?
| | Apoptosis | 3 | 2014 | 2395 | 0.080 |
Why?
| | Th1 Cells | 1 | 2011 | 139 | 0.080 |
Why?
| | HIV Infections | 1 | 2026 | 3148 | 0.080 |
Why?
| | Goblet Cells | 2 | 2020 | 22 | 0.080 |
Why?
| | Middle Aged | 8 | 2024 | 35892 | 0.080 |
Why?
| | DNA Primers | 2 | 2009 | 507 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3408 | 0.080 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 452 | 0.070 |
Why?
| | Proteins | 1 | 2015 | 1011 | 0.070 |
Why?
| | Latex | 1 | 2009 | 9 | 0.070 |
Why?
| | Curcumin | 1 | 2009 | 25 | 0.070 |
Why?
| | Pentanes | 1 | 2009 | 11 | 0.070 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 1177 | 0.070 |
Why?
| | Hemiterpenes | 1 | 2009 | 11 | 0.070 |
Why?
| | Elastomers | 1 | 2009 | 30 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 869 | 0.070 |
Why?
| | Emulsions | 1 | 2009 | 57 | 0.070 |
Why?
| | Immunoenzyme Techniques | 2 | 2010 | 196 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2013 | 575 | 0.070 |
Why?
| | Respiratory Function Tests | 2 | 2021 | 541 | 0.070 |
Why?
| | Respiratory System Agents | 1 | 2008 | 22 | 0.070 |
Why?
| | Pneumococcal Infections | 1 | 2009 | 103 | 0.070 |
Why?
| | Cell Extracts | 1 | 2008 | 21 | 0.070 |
Why?
| | Electric Stimulation | 2 | 2000 | 276 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2017 | 2134 | 0.070 |
Why?
| | Lipopolysaccharides | 2 | 2024 | 854 | 0.070 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 193 | 0.070 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2008 | 47 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2010 | 623 | 0.070 |
Why?
| | RNA, Messenger | 3 | 2017 | 2808 | 0.070 |
Why?
| | Gait | 1 | 2010 | 312 | 0.060 |
Why?
| | Recombination, Genetic | 1 | 2008 | 205 | 0.060 |
Why?
| | 3T3 Cells | 1 | 2007 | 156 | 0.060 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 164 | 0.060 |
Why?
| | Receptor, Adenosine A3 | 1 | 2006 | 1 | 0.060 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 338 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2007 | 246 | 0.060 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 245 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 390 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2010 | 770 | 0.060 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 425 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2017 | 334 | 0.060 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2026 | 25 | 0.060 |
Why?
| | ARNTL Transcription Factors | 1 | 2026 | 17 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 47 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2005 | 32 | 0.060 |
Why?
| | Sirtuin 1 | 1 | 2026 | 34 | 0.060 |
Why?
| | Bordetella pertussis | 1 | 2025 | 4 | 0.060 |
Why?
| | Period Circadian Proteins | 1 | 2026 | 33 | 0.060 |
Why?
| | Time Factors | 3 | 2011 | 7128 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 337 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1946 | 0.060 |
Why?
| | Walking | 1 | 2010 | 542 | 0.060 |
Why?
| | Nasopharynx | 1 | 2025 | 73 | 0.060 |
Why?
| | Nasal Mucosa | 1 | 2025 | 112 | 0.050 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 2004 | 4 | 0.050 |
Why?
| | Eye Proteins | 1 | 2024 | 85 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1920 | 0.050 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 659 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 2 | 2018 | 354 | 0.050 |
Why?
| | Adolescent | 2 | 2021 | 22370 | 0.050 |
Why?
| | Aerosols | 3 | 2010 | 187 | 0.050 |
Why?
| | Polyethylene Glycols | 1 | 2009 | 651 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 590 | 0.050 |
Why?
| | Up-Regulation | 1 | 2007 | 847 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 253 | 0.050 |
Why?
| | Trachea | 2 | 2020 | 258 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2127 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 339 | 0.050 |
Why?
| | Organoids | 1 | 2024 | 138 | 0.050 |
Why?
| | Mice, Mutant Strains | 2 | 2015 | 299 | 0.050 |
Why?
| | Ions | 1 | 2023 | 68 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 3324 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2896 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1784 | 0.050 |
Why?
| | Diffusion | 1 | 2023 | 122 | 0.050 |
Why?
| | Transcriptome | 2 | 2019 | 1034 | 0.050 |
Why?
| | Phenotype | 4 | 2014 | 3139 | 0.050 |
Why?
| | Aging | 1 | 2013 | 1935 | 0.040 |
Why?
| | Adult | 3 | 2021 | 40408 | 0.040 |
Why?
| | Balantidiasis | 1 | 2001 | 1 | 0.040 |
Why?
| | Cell Movement | 1 | 2026 | 957 | 0.040 |
Why?
| | Mechlorethamine | 1 | 2021 | 52 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 357 | 0.040 |
Why?
| | ErbB Receptors | 2 | 2018 | 626 | 0.040 |
Why?
| | Antibodies | 2 | 2000 | 396 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 197 | 0.040 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2000 | 4 | 0.040 |
Why?
| | Quinuclidines | 1 | 2000 | 11 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 819 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 93 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 204 | 0.040 |
Why?
| | Neutrophil Infiltration | 2 | 2012 | 104 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 99 | 0.040 |
Why?
| | Stem Cells | 1 | 2024 | 621 | 0.040 |
Why?
| | Trichinellosis | 1 | 2019 | 2 | 0.040 |
Why?
| | Trichinella spiralis | 1 | 2019 | 2 | 0.040 |
Why?
| | Cross Protection | 1 | 2019 | 5 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 749 | 0.040 |
Why?
| | Cyclophosphamide | 1 | 2000 | 265 | 0.040 |
Why?
| | Haemophilus Infections | 2 | 2010 | 45 | 0.040 |
Why?
| | Keratin-15 | 1 | 2019 | 16 | 0.040 |
Why?
| | Protein Binding | 2 | 2017 | 2241 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 153 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2014 | 2485 | 0.040 |
Why?
| | Surface Properties | 2 | 2012 | 397 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 675 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2019 | 5 | 0.040 |
Why?
| | Strongylida Infections | 1 | 2019 | 8 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2019 | 31 | 0.040 |
Why?
| | Histamine | 1 | 1999 | 53 | 0.040 |
Why?
| | Immunization | 1 | 2001 | 373 | 0.040 |
Why?
| | Hyperplasia | 1 | 2019 | 177 | 0.040 |
Why?
| | Heparin | 1 | 2000 | 242 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 416 | 0.040 |
Why?
| | Piperidines | 1 | 2000 | 218 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 34 | 0.040 |
Why?
| | Muscle Strength | 2 | 2013 | 330 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 53 | 0.040 |
Why?
| | Sri Lanka | 1 | 2018 | 7 | 0.030 |
Why?
| | Sputum | 1 | 2020 | 307 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2001 | 1300 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2019 | 206 | 0.030 |
Why?
| | Intestines | 1 | 2021 | 356 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2009 | 2194 | 0.030 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 156 | 0.030 |
Why?
| | Larva | 1 | 2019 | 244 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 559 | 0.030 |
Why?
| | Immunologic Techniques | 1 | 1997 | 38 | 0.030 |
Why?
| | Biomarkers, Tumor | 2 | 2018 | 1314 | 0.030 |
Why?
| | Chemokines | 2 | 2009 | 217 | 0.030 |
Why?
| | Body Composition | 2 | 2013 | 689 | 0.030 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 12 | 0.030 |
Why?
| | RNA Transport | 1 | 2017 | 27 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 167 | 0.030 |
Why?
| | Biopsy | 1 | 2001 | 1078 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 779 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2017 | 40 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 85 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 138 | 0.030 |
Why?
| | Thermodynamics | 2 | 2009 | 424 | 0.030 |
Why?
| | Acetylcholine | 1 | 1997 | 208 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 161 | 0.030 |
Why?
| | NF-kappa B | 2 | 2012 | 656 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 702 | 0.030 |
Why?
| | Epithelial Sodium Channels | 1 | 2016 | 21 | 0.030 |
Why?
| | Rabbits | 1 | 1997 | 646 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 5 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 5 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 7 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 16 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 29 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 28 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 61 | 0.030 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2015 | 14 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 63 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 324 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2015 | 3595 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2012 | 0.030 |
Why?
| | Mucin-4 | 1 | 2014 | 3 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 629 | 0.030 |
Why?
| | Aged | 5 | 2015 | 25901 | 0.030 |
Why?
| | Child | 3 | 2021 | 22562 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 971 | 0.030 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 65 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 534 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2015 | 113 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1306 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 248 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 569 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2017 | 351 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2012 | 4102 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2014 | 318 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 294 | 0.020 |
Why?
| | Musculoskeletal Physiological Phenomena | 1 | 2013 | 8 | 0.020 |
Why?
| | Whole Body Imaging | 1 | 2013 | 29 | 0.020 |
Why?
| | Child, Preschool | 2 | 2021 | 11767 | 0.020 |
Why?
| | Passive Cutaneous Anaphylaxis | 1 | 2012 | 3 | 0.020 |
Why?
| | E-Box Elements | 1 | 2012 | 5 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1046 | 0.020 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2012 | 30 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 138 | 0.020 |
Why?
| | Ligands | 1 | 2014 | 661 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 113 | 0.020 |
Why?
| | DNA Methylation | 1 | 2017 | 664 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2012 | 146 | 0.020 |
Why?
| | Cell Separation | 1 | 2013 | 302 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2012 | 219 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 276 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 407 | 0.020 |
Why?
| | Bronchoconstrictor Agents | 1 | 2011 | 14 | 0.020 |
Why?
| | Cecum | 1 | 2011 | 37 | 0.020 |
Why?
| | Arthropod Proteins | 1 | 2011 | 6 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2013 | 240 | 0.020 |
Why?
| | Nanoparticles | 1 | 2017 | 512 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 388 | 0.020 |
Why?
| | Airway Resistance | 1 | 2011 | 38 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2011 | 69 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 832 | 0.020 |
Why?
| | Particle Size | 1 | 2012 | 401 | 0.020 |
Why?
| | Materials Testing | 1 | 2012 | 349 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1160 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 273 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2014 | 733 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2011 | 249 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2012 | 494 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 922 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 982 | 0.020 |
Why?
| | Habits | 1 | 2010 | 52 | 0.020 |
Why?
| | Resistance Training | 1 | 2013 | 185 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1843 | 0.020 |
Why?
| | Speech | 1 | 2010 | 78 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2741 | 0.020 |
Why?
| | Cell Degranulation | 1 | 2009 | 41 | 0.020 |
Why?
| | Survival | 1 | 2009 | 38 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4293 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 323 | 0.020 |
Why?
| | Physical Exertion | 1 | 2010 | 205 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2011 | 315 | 0.020 |
Why?
| | Body Height | 1 | 2010 | 199 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1152 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1880 | 0.020 |
Why?
| | Molecular Weight | 1 | 2009 | 311 | 0.020 |
Why?
| | Physical Fitness | 1 | 2010 | 207 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 231 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2009 | 127 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2015 | 1331 | 0.020 |
Why?
| | Leg | 1 | 2010 | 239 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2008 | 76 | 0.020 |
Why?
| | Uridine Triphosphate | 1 | 2008 | 9 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2008 | 124 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2009 | 112 | 0.020 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 20 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2008 | 122 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 191 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 2032 | 0.020 |
Why?
| | Ozone | 1 | 2009 | 131 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 1182 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2008 | 89 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2011 | 781 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 472 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2008 | 272 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2010 | 715 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2009 | 318 | 0.020 |
Why?
| | Gene Silencing | 1 | 2008 | 202 | 0.020 |
Why?
| | Exons | 1 | 2008 | 359 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 888 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 886 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2008 | 201 | 0.020 |
Why?
| | Cell Shape | 1 | 2006 | 56 | 0.010 |
Why?
| | Cell Survival | 1 | 2009 | 1092 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 376 | 0.010 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 16 | 0.010 |
Why?
| | Receptors, CCR3 | 1 | 2005 | 7 | 0.010 |
Why?
| | Body Weight | 1 | 2010 | 968 | 0.010 |
Why?
| | Chemokine CCL11 | 1 | 2005 | 25 | 0.010 |
Why?
| | Parasympathetic Nervous System | 1 | 2005 | 26 | 0.010 |
Why?
| | Survival Rate | 1 | 2010 | 2081 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 380 | 0.010 |
Why?
| | Models, Genetic | 1 | 2008 | 531 | 0.010 |
Why?
| | Motor Activity | 1 | 2010 | 723 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 666 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1809 | 0.010 |
Why?
| | History, 20th Century | 1 | 2006 | 327 | 0.010 |
Why?
| | Alleles | 1 | 2008 | 881 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1373 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5553 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 862 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6387 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1206 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1437 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2844 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2008 | 1158 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 14092 | 0.010 |
Why?
| | Infant | 1 | 2015 | 10011 | 0.010 |
Why?
| | Diamines | 1 | 1999 | 5 | 0.010 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1999 | 15 | 0.010 |
Why?
| | Muscarinic Agonists | 1 | 1999 | 14 | 0.010 |
Why?
| | Vagotomy | 1 | 1999 | 33 | 0.010 |
Why?
| | Integrin alpha4beta1 | 1 | 1999 | 8 | 0.010 |
Why?
| | Atropine | 1 | 1999 | 37 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1999 | 30 | 0.010 |
Why?
| | Integrins | 1 | 1999 | 90 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8265 | 0.010 |
Why?
| | Pregnancy | 1 | 2009 | 7112 | 0.010 |
Why?
|
|
Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|